
MLSS Valuation
Milestone Scientific Inc
- Overview
- Forecast
- Valuation
- Earnings
MLSS Relative Valuation
MLSS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MLSS is overvalued; if below, it's undervalued.
Historical Valuation
Milestone Scientific Inc (MLSS) is now in the Fair zone, suggesting that its current forward PS ratio of 4.51 is considered Fairly compared with the five-year average of -16.31. The fair price of Milestone Scientific Inc (MLSS) is between 0.56 to 1.58 according to relative valuation methord.
Relative Value
Fair Zone
0.56-1.58
Current Price:0.59
Fair
-8.43
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Milestone Scientific Inc. (MLSS) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
-7.89
EV/EBIT
Milestone Scientific Inc. (MLSS) has a current EV/EBIT of -7.89. The 5-year average EV/EBIT is -12.78. The thresholds are as follows: Strongly Undervalued below -23.46, Undervalued between -23.46 and -18.12, Fairly Valued between -7.44 and -18.12, Overvalued between -7.44 and -2.10, and Strongly Overvalued above -2.10. The current Forward EV/EBIT of -7.89 falls within the Historic Trend Line -Fairly Valued range.
4.51
PS
Milestone Scientific Inc. (MLSS) has a current PS of 4.51. The 5-year average PS is 8.60. The thresholds are as follows: Strongly Undervalued below -1.14, Undervalued between -1.14 and 3.73, Fairly Valued between 13.47 and 3.73, Overvalued between 13.47 and 18.33, and Strongly Overvalued above 18.33. The current Forward PS of 4.51 falls within the Historic Trend Line -Fairly Valued range.
231.79
P/OCF
Milestone Scientific Inc. (MLSS) has a current P/OCF of 231.79. The 5-year average P/OCF is -4.78. The thresholds are as follows: Strongly Undervalued below -168.82, Undervalued between -168.82 and -86.80, Fairly Valued between 77.24 and -86.80, Overvalued between 77.24 and 159.26, and Strongly Overvalued above 159.26. The current Forward P/OCF of 231.79 falls within the Strongly Overvalued range.
0.00
P/FCF
Milestone Scientific Inc. (MLSS) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Milestone Scientific Inc (MLSS) has a current Price-to-Book (P/B) ratio of 13.88. Compared to its 3-year average P/B ratio of 8.34 , the current P/B ratio is approximately 66.33% higher. Relative to its 5-year average P/B ratio of 8.07, the current P/B ratio is about 71.99% higher. Milestone Scientific Inc (MLSS) has a Forward Free Cash Flow (FCF) yield of approximately -11.36%. Compared to its 3-year average FCF yield of -8.10%, the current FCF yield is approximately 40.30% lower. Relative to its 5-year average FCF yield of -6.81% , the current FCF yield is about 66.91% lower.
13.88
P/B
Median3y
8.34
Median5y
8.07
-11.36
FCF Yield
Median3y
-8.10
Median5y
-6.81
Competitors Valuation Multiple
The average P/S ratio for MLSS's competitors is 5.54, providing a benchmark for relative valuation. Milestone Scientific Inc Corp (MLSS) exhibits a P/S ratio of 4.51, which is -18.66% above the industry average. Given its robust revenue growth of 25.34%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MLSS decreased by 35.15% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -1.02 to -6.81.
The secondary factor is the Revenue Growth, contributed 25.34%to the performance.
Overall, the performance of MLSS in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch

IROH
Iron Horse Acquisitions Corp
9.770
USD
-13.62%

SHIM
Shimmick Corp
3.000
USD
-3.85%

ALXO
ALX Oncology Holdings Inc
1.170
USD
+2.63%

CODA
Coda Octopus Group Inc
8.105
USD
+1.19%

ALOT
AstroNova Inc
11.420
USD
+9.70%

CTOR
Citius Oncology Inc
2.170
USD
+2.36%

ORMP
Oramed Pharmaceuticals Inc
2.200
USD
0.00%

PAVS
Paranovus Entertainment Technology Ltd
0.716
USD
+3.77%

HSPO
Horizon Space Acquisition I Corp
12.230
USD
0.00%

VOR
Vor Biopharma Inc
1.970
USD
-1.99%
FAQ

Is Milestone Scientific Inc (MLSS) currently overvalued or undervalued?
Milestone Scientific Inc (MLSS) is now in the Fair zone, suggesting that its current forward PS ratio of 4.51 is considered Fairly compared with the five-year average of -16.31. The fair price of Milestone Scientific Inc (MLSS) is between 0.56 to 1.58 according to relative valuation methord.

What is Milestone Scientific Inc (MLSS) fair value?

How does MLSS's valuation metrics compare to the industry average?

What is the current P/B ratio for Milestone Scientific Inc (MLSS) as of Sep 01 2025?

What is the current FCF Yield for Milestone Scientific Inc (MLSS) as of Sep 01 2025?

What is the current Forward P/E ratio for Milestone Scientific Inc (MLSS) as of Sep 01 2025?
